The Executive Committee, composed by members of the managing MS Societes, is the decision making body for the Progressive MS Alliance and has the authority to act on its behalf. It leads all aspects of the Alliance including planning and budgeting, scientific review, research funding, communications and fundraising.

he Scientific Steering Committee consists of staff and volunteers (scientific experts and people with MS) appointed by Alliance members. It guides the scientific direction and research activities of the Alliance and oversees the work of the Scientific Review Committees and the Scientific Operations Work Group.

Involvement of the pharmaceutical and biotechnology industry is fundamental in achieving the mission of the Alliance. This sector has the capacity to contribute knowledge and resources needed to drive drug discovery and development in progressive MS. Industry participates in the work of the Alliance through the Industry Forum, the venue for industry to provide advice and recommendations to the Alliance Scientific Steering Committee and contribute financial support towards the ongoing research initiatives of the Alliance.